PolyPid (PYPD) furnishes Q3 2025 results and corporate update on 6-K

Rhea-AI Filing Summary

PolyPid Ltd. submitted a Form 6-K to furnish a press release titled “PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results.” The filing notes that the press release includes recent corporate highlights, financial results for the three and nine months ended September 30, 2025, balance sheet highlights and forward-looking statements.

These specific sections of the press release, along with the attached financial statements, are incorporated by reference into multiple existing PolyPid registration statements on Forms F-3 and S-8, so they become part of those offerings from the date of this report, unless later filings supersede them.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of: November 2025

Commission File Number: 001-38428

PolyPid Ltd.

(Translation of registrant’s name into English)

18 Hasivim Street

Petach Tikva 495376, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F      ☐ Form 40-F

CONTENTS

Attached hereto and incorporated herein is PolyPid Ltd.’s (the “Registrant”) press release issued on November 12, 2025, titled “PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results.”

The bullet points under the section titled “Recent Corporate Highlights,” the sections titled “Financial results for three months ended September 30, 2025,” “Financial results for nine months ended September 30, 2025,” “Balance Sheet Highlights,” and “Forward-looking Statements” and the financial statements in the press release are incorporated by reference into the Registrant’s registration statements on Form F-3 (File No. 333-276826, File No. 333-280658, File No. 333-281863, File No. 333-284376 and File No. 333-289034)  and Form S-8 (File No. 333-239517, File No. 333-271060, File No. 333-277703, File No. 333-280662 and File No. 333-289570) filed  with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. 

1

EXHIBIT INDEX

Exhibit No.
99.1		Press release issued by PolyPid Ltd. on November 12, 2025, titled “PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results.”

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	POLYPID LTD.
Date: November 12, 2025	By:	/s/ Dikla Czaczkes Akselbrad
		Name:	Dikla Czaczkes Akselbrad
		Title:	Chief Executive Officer

3

FAQ

What does PolyPid (PYPD) report in this Form 6-K?

The Form 6-K furnishes a press release titled “PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results,” which includes recent corporate highlights, quarterly and year-to-date financial results, balance sheet highlights and forward-looking statements.

Which periods do PolyPid’s financial results in this update cover?

The furnished press release includes financial results for the three months ended September 30, 2025 and financial results for the nine months ended September 30, 2025, as well as balance sheet highlights.

How is this Form 6-K used in relation to PolyPid’s F-3 registration statements?

The bullet points under “Recent Corporate Highlights,” the financial results sections, “Balance Sheet Highlights,” “Forward-looking Statements,” and the financial statements in the press release are incorporated by reference into PolyPid’s registration statements on Form F-3 (File Nos. 333-276826, 333-280658, 333-281863, 333-284376 and 333-289034).

How does this Form 6-K affect PolyPid’s S-8 registration statements?

The same specified sections of the press release and its financial statements are incorporated by reference into PolyPid’s Form S-8 registration statements (File Nos. 333-239517, 333-271060, 333-277703, 333-280662 and 333-289570), making them part of those filings from the date of this report unless later superseded.

What exhibit is attached to PolyPid’s November 2025 Form 6-K?

The Form 6-K includes Exhibit 99.1, which is the press release issued by PolyPid Ltd. on November 12, 2025 titled “PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results.”

Who signed PolyPid’s Form 6-K for November 2025?

The report was signed on behalf of PolyPid Ltd. by Dikla Czaczkes Akselbrad, who is identified as the company’s Chief Executive Officer.